Fortitude Family Office’s Day One Biopharmaceuticals DAWN Stock Holding History

Fortitude Family Office’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23	Closed	-$493	–	2296
2026 Q1	$493	Buy	+23	New	+$324	﹤0.01%	1735

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fortitude Family Office's DAWN Position: Q2 2026 in Review

Fortitude Family Office sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 23 shares — an estimated $493 sold.

Fortitude Family Office first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $493 in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Fortitude Family Office reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fortitude Family Office sold 23 Day One Biopharmaceuticals shares in Q2 2026, an estimated $493.
Fortitude Family Office first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Fortitude Family Office's Day One Biopharmaceuticals position peaked at $493 in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.